Abstract
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have